Are Investors Undervaluing Cabot (CBT) Right Now?
https://www.zacks.com/stock/news/2274077/are-investors-undervaluing-cabot-cbt-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2274077
May 15, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0
Cabot (CBT) Is Up 0.56% in One Week: What You Should Know
https://www.zacks.com/stock/news/2272390/cabot-cbt-is-up-0-56-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2272390
May 10, 2024 - Does Cabot (CBT) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
3 Reasons Growth Investors Will Love Cabot (CBT)
https://www.zacks.com/stock/news/2271703/3-reasons-growth-investors-will-love-cabot-cbt?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_11_growth-2271703
May 09, 2024 - Cabot (CBT) could produce exceptional returns because of its solid growth attributes.
0
Why Cabot (CBT) is a Top Value Stock for the Long-Term
https://www.zacks.com/stock/news/2247346/why-cabot-cbt-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2247346
Mar 28, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2239245/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2239245
Mar 12, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
Better Therapeutics' (BTTX) CBT Gains FDA's Breakthrough Status
https://www.zacks.com/stock/news/2230299/better-therapeutics-bttx-cbt-gains-fda-s-breakthrough-status?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2230299
Feb 22, 2024 - Better Therapeutics' (BTTX) novel CBT platform attains the FDA's breakthrough device designation to improve patient care in the treatment of liver and metabolic diseases.
0
Why Cabot (CBT) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2230218/why-cabot-cbt-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2230218
Feb 22, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
Are You Looking for a High-Growth Dividend Stock?
https://www.zacks.com/stock/news/2215152/are-you-looking-for-a-high-growth-dividend-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-2215152
Jan 24, 2024 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Cabot (CBT) have what it takes? Let's find out.
0
Best Value Stocks to Buy for January 15th
https://www.zacks.com/commentary/2210014/best-value-stocks-to-buy-for-january-15th?cid=CS-ZC-FT-zacks_1_rank_additions|value_additions-2210014
Jan 15, 2024 - RGA, PAX and CBT made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 15, 2024.
0
Arkema (ARKAY) Backs Tiamat for Lithium-Free Battery Innovation
https://www.zacks.com/stock/news/2209961/arkema-arkay-backs-tiamat-for-lithium-free-battery-innovation?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2209961
Jan 15, 2024 - Arkema (ARKAY) invests in Tiamat, accelerating the development of lithium-free solutions and supporting the construction of a dedicated 5 GWh Giga-factory in France.
0
Pages: 12
Page 1